Clinical Trial Update: Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing pharmacokinetics and pharmacodynamics of oral baclofen in children with spasticity due to cerebral palsy (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Spasticity, Cerebral Palsy | Phase 1, Phase 2 | Status: COMPLETED